Compumedics Stock Forecast for 2023 - 2025 - 2030
Updated on 05/08/2024
Compumedics Fair Value Forecast for 2023 - 2025 - 2030
Compumedics's Price has grown In the last four years, rising from $0.00 to $0.00 – a growth of 100.00%. In the next year, analysts believe that Fair Value will reach $0.00 – an increase of 100.00%. For the next six years, experts predict that Compumedics's Fair Value will grow at a rate of 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| NAN Stock Forecast | Nanosonics | Hold |
14
|
$2.92 | Buy/Sell | $4.65 | 2.40% |
| EMV Stock Forecast | EMVision Medical Devices Ltd | - |
4
|
$1.97 | Buy/Sell | $2.30 | -100.00% |
| IPD Stock Forecast | ImpediMed | Buy |
9
|
$0.08 | Buy/Sell | $0.22 | 125.00% |
| CYC Stock Forecast | Cyclopharm | Buy |
7
|
$1.72 | Buy/Sell | $3.17 | 67.44% |
| EYE Stock Forecast | Nova Eye Medical | Outperform |
0
|
$0.27 | Buy/Sell | $0.51 | 85.19% |
Compumedics Revenue Forecast for 2023 - 2025 - 2030
Compumedics's Revenue has grown In the last three years, rising from $35.07M to $42.92M – a growth of 22.38%. In the following year, 0 experts forecast Compumedics's Revenue will decrease by 6.41%, to $40.17M. In 2030, professionals predict that Compumedics's Revenue will decrease by 8.50%, to $39.27M.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| SPX Stock Forecast | Spenda | - |
9
|
$0.01 | Buy/Sell | $0.00 | -100.00% |
| LBT Stock Forecast | LBT Innovations | - |
-7
|
$0.02 | Buy/Sell | $0.20 | -100.00% |
| RHT Stock Forecast | Resonance Health | - |
0
|
$0.05 | Buy/Sell | $0.00 | -100.00% |
.jpg)
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| RSH Stock Forecast | Respiri | - |
0
|
$0.03 | Buy/Sell | $0.00 | -100.00% |
| CDX Stock Forecast | CardieX |
0
|
$0.06 | Buy/Sell | $0.00 | 733.33% | |
| BPP Stock Forecast | Babylon Pump & Power | - |
0
|
$0.01 | Buy/Sell | $0.00 | -100.00% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| ADR Stock Forecast | Adherium | - |
0
|
$0.02 | Buy/Sell | $0.33 | -100.00% |
| DVL Stock Forecast | dorsaVi Ltd | - |
0
|
$0.01 | Buy/Sell | $0.40 | -100.00% |
| UCM Stock Forecast | Uscom | - |
0
|
$0.03 | Buy/Sell | $0.00 | -100.00% |
Compumedics EBITDA Forecast for 2023 - 2025 - 2030
In the last three years, Compumedics's EBITDA has fallen from $1.29M to $-2.60M – a 301.55% decrease. In the next year, analysts predict that EBITDA will jump to $-3.82M – up 47.09% from the current level. Looking ahead to seven years, experts forecast that EBITDA will grow by 138.79%.
Compumedics EBIT Forecast for 2023 - 2025 - 2030
In the last three years, Compumedics's EBIT has decreased from $510.00k to $-3.02M – a 692.16% drop. Analysts predict that Compumedics's EBIT will increase in the upcoming year, reaching $-3.69M. This would represent an increase of 22.26%. Over the next seven years, experts predict that Compumedics's EBIT will grow at a rate of 85.24%.
Compumedics EPS Price Prediction Forecast for 2023 - 2025 - 2030
Compumedics's EPS has grown In the last four years, rising from $0.00 to $0.00 – a growth of 100.00%. In the next year, analysts believe that EPS will reach $0.00 – an increase of 100.00%. For the next six years, experts predict that Compumedics's EPS will grow at a rate of 100.00%.
.jpg)